tradingkey.logo
tradingkey.logo
Buscar

Champions Oncology Inc

CSBR
Añadir a la lista de seguimiento
5.960USD
-0.085-1.41%
Cierre 07/02, 13:00ETCotizaciones retrasadas 15 min
82.77MCap. mercado
PérdidaP/E TTM

Más Datos de Champions Oncology Inc Compañía

Champions Oncology, Inc. is a preclinical and clinical research services provider. The Company is engaged in the development and sale of advanced technology solutions and products to personalize the development and use of oncology drugs through its translational oncology solutions. This technology ranges from computational-based discovery platforms, oncology software solutions, and proprietary experimental tools such as in vivo, ex vivo and biomarker platforms. Utilizing its TumorGraft Technology Platform (the Platform), it provides select services to pharmaceutical and biotechnology companies seeking personalized approaches to drug development. It also sells Lumin Bioinformatics (Lumin), an oncology data-driven software program which contains comprehensive information derived from its research services and clinical studies. Lumin leverages a large data center coupled with analytics and artificial intelligence to provide a robust tool for computational cancer research.

Información de Champions Oncology Inc

Símbolo de cotizaciónCSBR
Nombre de la empresaChampions Oncology Inc
Fecha de salida a bolsaNov 30, 1988
Director ejecutivoBrainin (Robert)
Número de empleados213
Tipo de seguridadOrdinary Share
Fin del año fiscalNov 30
DirecciónOne University Plaza,
CiudadHACKENSACK
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal07601
Teléfono12018088400
Sitio Webhttps://championsoncology.com
Símbolo de cotizaciónCSBR
Fecha de salida a bolsaNov 30, 1988
Director ejecutivoBrainin (Robert)

Ejecutivos de Champions Oncology Inc

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Joel Ackerman
Mr. Joel Ackerman
Independent Director
Independent Director
1.06M
+8.94%
Dr. Ronnie Morris, M.D.
Dr. Ronnie Morris, M.D.
Chairman of the Board
Chairman of the Board
858.88K
--
Dr. David Sidransky, M.D.
Dr. David Sidransky, M.D.
Independent Director
Independent Director
767.04K
--
Mr. Scott R. Tobin
Mr. Scott R. Tobin
Independent Director
Independent Director
53.40K
+43.82%
Mr. Daniel N. (Dan) Mendelson
Mr. Daniel N. (Dan) Mendelson
Independent Director
Independent Director
--
--
Mr. David Miller, CPA
Mr. David Miller, CPA
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Philip Breitfeld, M.D.
Dr. Philip Breitfeld, M.D.
Independent Director
Independent Director
--
--
Mr. Robert (Rob) Brainin
Mr. Robert (Rob) Brainin
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Joel Ackerman
Mr. Joel Ackerman
Independent Director
Independent Director
1.06M
+8.94%
Dr. Ronnie Morris, M.D.
Dr. Ronnie Morris, M.D.
Chairman of the Board
Chairman of the Board
858.88K
--
Dr. David Sidransky, M.D.
Dr. David Sidransky, M.D.
Independent Director
Independent Director
767.04K
--
Mr. Scott R. Tobin
Mr. Scott R. Tobin
Independent Director
Independent Director
53.40K
+43.82%
Mr. Daniel N. (Dan) Mendelson
Mr. Daniel N. (Dan) Mendelson
Independent Director
Independent Director
--
--
Mr. David Miller, CPA
Mr. David Miller, CPA
Chief Financial Officer
Chief Financial Officer
--
--

Preguntas frecuentes

¿Quiénes son los cinco principales accionistas de Champions Oncology Inc?

Los cinco principales accionistas de Champions Oncology Inc son: Mr. Joel Ackerman

¿Cuántas instituciones poseen acciones de Champions Oncology Inc (CSBR)?

A fecha de 2026Q1, 61 instituciones poseen acciones de Champions Oncology Inc, con un valor de mercado combinado de aproximadamente 6.66M, lo que representa el 47.97% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en -413745.00.